ID: ALA3642243

Max Phase: Preclinical

Molecular Formula: C18H25F3N2O2

Molecular Weight: 358.40

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(N1CCC(NC(=O)C23CC4CC(CC(C4)C2)C3)CC1)C(F)(F)F

Standard InChI:  InChI=1S/C18H25F3N2O2/c19-18(20,21)16(25)23-3-1-14(2-4-23)22-15(24)17-8-11-5-12(9-17)7-13(6-11)10-17/h11-14H,1-10H2,(H,22,24)

Standard InChI Key:  CRYFMZCAXMLESD-UHFFFAOYSA-N

Associated Targets(Human)

Epoxide hydrolase 1 644 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 358.40Molecular Weight (Monoisotopic): 358.1868AlogP: 2.87#Rotatable Bonds: 2
Polar Surface Area: 49.41Molecular Species: NEUTRALHBA: 2HBD: 1
#RO5 Violations: 0HBA (Lipinski): 4HBD (Lipinski): 1#RO5 Violations (Lipinski): 0
CX Acidic pKa: CX Basic pKa: 0.99CX LogP: 2.18CX LogD: 2.18
Aromatic Rings: 0Heavy Atoms: 25QED Weighted: 0.83Np Likeness Score: -1.21

References

1.  (2013)  Conformationally restricted urea inhibitors of soluble epoxide hydrolase, 

Source

Source(1):